Physician

Jay E Sidloski, DO

According to 2025 Medicare claims, Jay Sidloski, DO (NPI: 1912950502) practices hematology/oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lorain, OH. This provider's primary affiliated billing organization is AMERICAN ONCOLOGY PARTNERS PA (NPI: 1265929723; TIN: 824681345) and primary practice location at 44035-2249. Sidloski is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Sidloski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 604 traditional Medicare patients, billed 141,591 HCPCS/CPT codes, and received $2,665,652 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,022 prescription claims across 399 beneficiaries totaling $5,745,971 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 67 claims. Open Payments data shows 104 records totaling $2,419. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,227,219 and ending at $2,665,652. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,059,617 to $5,745,971. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	833	142,263	$1,227,219
2016	909	124,765	$1,228,535
2017	819	110,149	$1,536,245
2018	766	135,245	$1,635,026
2019	569	83,481	$1,154,519
2020	558	107,511	$1,597,893
2021	472	101,354	$1,167,358
2022	455	65,828	$1,116,283
2023	728	157,856	$2,586,907
2024	604	141,591	$2,665,652

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	345	1,906	$2,059,617
2016	384	2,039	$2,268,443
2017	363	1,937	$2,357,459
2018	369	1,839	$3,104,818
2019	368	1,945	$3,383,175
2020	348	2,076	$4,173,027
2021	333	2,002	$4,261,976
2022	359	2,003	$4,721,724
2023	407	2,094	$4,948,393
2024	399	2,022	$5,745,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	92	$30,867
2016	28	103	$37,684
2017	N/R	59	$21,841
2018	11	53	$10,256
2019	N/R	34	$3,645
2020	N/R	24	$2,034
2021	N/R	N/R	N/R
2022	N/R	11	$732
2023	N/R	23	$3,314
2024	N/R	67	$1,548

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	71	71	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	126	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	433	819	$59
36415	Insertion of needle into vein for collection of blood sample	469	1,511	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	480	1,600	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	58	1,642	$812,375
Pomalyst	Pomalidomide	47	1,190	$764,279
Ibrance	Palbociclib	57	1,608	$737,127
Revlimid	Lenalidomide	48	1,357	$725,430
Lenalidomide	Lenalidomide	20	560	$342,294

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	11	$483
J8521	Capecitabine, oral, 500 mg	N	N/R	15	$421
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	19	$358
K0001	Standard wheelchair	Y	N/R	11	$197
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	11	$90

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	104	$2,419	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jay E. Sidloski, DO?

Tedicare shows public-source Medicare data for Jay E. Sidloski, DO (NPI 1912950502), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jay E. Sidloski, DO have ACO affiliation data?

Jay E. Sidloski, DO is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Jay E. Sidloski, DO?

Jay E. Sidloski, DO is linked to AMERICAN ONCOLOGY PARTNERS PA (billing NPI 1265929723) in the available physician profile data.

Does Jay E. Sidloski, DO have Open Payments data?

Jay E. Sidloski, DO has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.